BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8467984)

  • 1. [EGF receptor and EGF-like activity as prognostic factors in cervix cancer].
    Stellwag B; Scheidel P; Pfeiffer D; Hepp H
    Geburtshilfe Frauenheilkd; 1993 Mar; 53(3):177-81. PubMed ID: 8467984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix.
    Pfeiffer D; Stellwag B; Pfeiffer A; Borlinghaus P; Meier W; Scheidel P
    Gynecol Oncol; 1989 May; 33(2):146-50. PubMed ID: 2784777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical studies on epidermal growth factor receptor in oncogenesis of uterine cervical cancer].
    Ueda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1401-8. PubMed ID: 2685140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
    Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
    Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
    Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical search for lymph node metastases in females with surgically treated cervix cancer].
    Gitsch G; Reinthaller A; Kohlberger P; Breitenecker G
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():111. PubMed ID: 1286306
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunohistochemical studies on epidermal growth factor receptor and the myc oncogene product in squamous cell carcinoma of the uterine cervix].
    Yamasaki M; Maruo T; Akahori T; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jan; 40(1):51-8. PubMed ID: 3280708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of epidermal growth factor (EGF) receptors in basal cell carcinomas, squamous cell carcinomas and melanomas].
    Hagedorn M; Vanscheidt W; Strasser W; Bauknecht T
    Z Hautkr; 1990 Jun; 65(6):568-70. PubMed ID: 2389590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uterus corpus extension of primary cervical carcinoma IIA-IIB].
    Smutek J; Wójcik D; Mielnik J; Jurczak-Czaplicka M; Gniadek R
    Ginekol Pol; 2001 Aug; 72(8):618-23. PubMed ID: 11599246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of cervix cancer--yes or no to postoperative radiation treatment after Wertheim operation?].
    Baltzer J
    Zentralbl Gynakol; 1991; 113(11):661-5. PubMed ID: 1927113
    [No Abstract]   [Full Text] [Related]  

  • 11. Absence of epidermal growth factor receptor expression in squamous cell carcinoma of the uterine cervix is an indicator of limited tumor disease.
    Biesterfeld S; Schuh S; Muys L; Rath W; Mittermayer C; Schröder W
    Oncol Rep; 1999; 6(1):205-9. PubMed ID: 9864429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of lymph node status and lymph node morphology in cervix cancer operated by the Wertheim-Meigs-Okabayashi method].
    Geppert M; Smyczek-Gargya B; Dekorsy A; König PA
    Zentralbl Gynakol; 1992; 114(3):122-6. PubMed ID: 1595306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphoscintigraphy with (123)I-marked epidermal growth factor in cervix cancer].
    Schatten C; Pateisky N; Vavra N; Angelberger P; Ehrenböck P; Barrada M; Epenetos AA
    Gynakol Geburtshilfliche Rundsch; 1992; 32(1):17-21. PubMed ID: 1515777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymph node metastasis in microcarcinoma of the uterine cervix].
    Rohde E; Tessmann D
    Zentralbl Gynakol; 1993; 115(3):133-5. PubMed ID: 8465626
    [No Abstract]   [Full Text] [Related]  

  • 16. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
    Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
    Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of recurrence pattern and prognosis of patients with cervical carcinoma and pelvic lymph node metastasis].
    Xiong Y; Liang LZ; Zheng M; Wang LH; Deng PF; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jun; 43(6):425-8. PubMed ID: 19035136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
    Kristensen GB; Holm R; Abeler VM; Tropé CG
    Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic effect of scintigraphy-guided lymphadenectomy in therapy of stage Ib cervix carcinoma].
    Schatten C; Vavra N; Nagele F; Barrada M; Aygün M; Enzelsberger H; Sevelda P
    Geburtshilfe Frauenheilkd; 1995 Aug; 55(8):441-6. PubMed ID: 7557219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoscintigraphy using epidermal growth factor as tumour-seeking agent in uterine cervical cancer.
    Pateisky N; Schatten C; Vavra N; Ehreböck P; Angelberger P; Barrada M; Epenetos A
    Wien Klin Wochenschr; 1991; 103(21):654-6. PubMed ID: 1771899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.